Jun‐ichi Shishikura

YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.

M Takahashi, Jian Wei Ni, Sachiko Kawasaki‐Yatsugi et al. · PubMed · 1998 · 48 citations

Medicine, Neuroscience, Pharmacology +15

In-vitro Characterization of YM872, a Selective, Potent and Highly Water-soluble α-Amino-3-hydroxy-5-methylisoxazole-4- propionate Receptor Antagonist

Atsuyuki Kohara, Masamichí Okada, Rie Tsutsumi et al. · Journal of Pharmacy and Pharmacology · 1998 · 46 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Effects of 2-[N-(4-Chlorophenyl)-N-methylamino]-4 H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an Orally Active α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist, in Models of Generalized Epileptic Seizure in Mice and Rats

Hiroshi Yamashita, K Ohno, Yoko Amada et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 32 citations

Medicine, Neuroscience, Pharmacology +12

YM872, a Novel Selective α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Antagonist, Reduces Brain Damage after Permanent Focal Cerebral Ischemia in Cats

Masayasu Takahashi, Jian Wei Ni, Sachiko Kawasaki‐Yatsugi et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 28 citations

Medicine, Neuroscience, Pharmacology +14

Functional Characterization of YM928, a Novel Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist

K Ohno, Rie Tsutsumi, Naoyuki Matsumoto et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 25 citations

Medicine, Neuroscience, Pharmacology +17